Archives
-
2-Thio-dCTP: Research Context and Evidence
2026-10-08
2-Thio-dCTP is a sulfur-substituted deoxycytidine triphosphate used as a research nucleotide analog. This overview distinguishes supplier-described applications in DNA polymerase and DNA–protein interaction studies from the independent findings of a 2026 EMBO Reports study on SCP4, histone H3T3 dephosphorylation, and chromosome stability.
-
JC-1 Assay and Mitochondrial Homeostasis in Bladder Cancer
2026-10-08
This source-grounded overview examines how mitochondrial membrane potential research may contextualize recent findings on LRG1, neutrophils, NETosis, and pathological angiogenesis in bladder cancer. It distinguishes the published study’s evidence from conceptual applications of JC-1, while outlining assay limitations, translational boundaries, and the need for orthogonal mitochondrial measurements.
-
Protein A/G Magnetic Co-IP/IP Kit: Evidence Lens
2026-10-07
Explore how the Protein A/G Magnetic Co-IP/IP Kit supports evidence-led protein complex research, using UBC9–PINK1 SUMOylation in Parkinson’s disease as a case study. This article distinguishes molecular association from causal mechanism and explains where magnetic immunoprecipitation fits within a rigorous validation framework.
-
iRhom2 in Olfaction: OR Regulation and Adaptation
2026-10-07
Azzopardi and colleagues identify iRhom2 as a distinctive olfactory sensory neuron component and connect its expression with odor-dependent transcriptional adaptation. The study combines mouse genetics, transcriptomics, spatial analysis, and a receptor-cell model to support an iRhom2–ADAM17 signaling hypothesis while leaving direct neuronal causality unresolved.
-
Alosetron and Intestinal Stem Cell Research
2026-10-06
Alosetron is a selective 5-HT3 receptor antagonist associated with gastrointestinal motility modulation and visceral pain signaling research. A separate Cell Reports study established that CDC42-dependent epithelial polarity regulates intestinal stem cell and transit-amplifying cell balance through a YAP/TAZ–epiregulin–mTOR axis. This overview compares those evidence streams, explains possible conceptual links, and emphasizes that the published CDC42 study did not test alosetron or 5-HT3 receptor signaling. Any connection between alosetron and intestinal stem cell polarity therefore remains a hypothesis rather than an established finding.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-10-06
The 2026 FASEB Journal study evaluates chemically modified p21 mRNA delivered in lipid nanoparticles as a localized tumor suppressor replacement strategy for bladder cancer. Its preclinical evidence links bladder-localized expression with cell-cycle suppression, DNA-damage signaling, apoptosis, and reduced tumor growth, while also highlighting the limits of translating mouse-model findings into clinical treatment.
-
Tunicamycin, ER Stress, and Inflammation Research
2026-10-05
A source-grounded overview of Tunicamycin as a N-glycosylation inhibitor and endoplasmic reticulum stress inducer, with emphasis on macrophage-related claims, endothelial inflammation, ATF6 signaling, evidence strength, and translational limitations.
-
Z-WEHD-FMK as a Lens on Pyroptosis
2026-10-05
Z-WEHD-FMK can help researchers interpret inflammatory caspase dependence without treating pharmacological rescue as proof of a single molecular target. This article connects the inhibitor’s reported profile with the HOXC8–caspase-1 findings in lung cancer and defines the evidence boundaries for inflammation research, apoptosis assay design, and infectious disease research.
-
OMV-Displayed mRNA Antigens for Tumor Vaccines
2026-10-04
The reference study presents engineered bacteria-derived outer membrane vesicles as a surface-display platform for rapid mRNA antigen delivery. By combining L7Ae-mediated RNA capture with listeriolysin O-associated endosomal escape, the authors report antitumor activity, complete regression in a subset of mice, and protection against later tumor challenge, while emphasizing that the evidence remains preclinical.
-
RNA-Responsive Pyroptosis: Evidence and Limits
2026-10-03
A source-grounded overview of DAMAGE, a type III-E CRISPR nuclease-protease system reported to connect target RNA recognition with gasdermin-mediated pyroptosis. The article examines the study’s conceptual design, reported findings, possible research applications, evidence strength, assay context, and important limitations without presenting experimental procedures.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-10-02
The reference study develops chemically modified p21 mRNA packaged in lipid nanoparticles for localized intravesical treatment of bladder cancer. Its preclinical data connect restored nuclear p21 expression with cell-cycle inhibition, DNA-damage signaling, apoptosis, bladder-localized protein expression, and reduced tumor growth.
-
Arachidonic Acid: Assays, Workflows & Troubleshooting
2026-10-01
Build better lipid-signaling experiments with Arachidonic Acid, from controlled eicosanoid biosynthesis assays to immune-response workflows. This guide connects practical formulation and sampling choices with emerging evidence that arachidonate metabolism can accelerate vaccine-induced humoral immunity.
-
TRPV1 Somatosensory Nerves Suppress Inflammation
2026-10-01
The 2025 iScience study shows that activating TRPV1-positive peripheral afferents at the nape engages a somato-autonomic reflex that limits systemic inflammation. Its combination of neural-circuit mapping, cytokine analysis, genetic validation, hormone measurements, and splenic RNA sequencing connects sensory stimulation with coordinated vagal, sympathetic, and immune regulation.
-
SR-202: PPARγ Mechanism Studies
2026-09-30
SR-202 enables loss-of-function testing of PPARγ in adipocyte differentiation, macrophage polarization, and metabolic inflammation. This workflow pairs selective antagonism with pathway-resolved controls, helping distinguish PPARγ-dependent biology from nonspecific changes in viability or transcription.
-
Mitochondrial Permeability Transition Pore Assay Kit Guide
2026-09-30
Learn how to use a Calcein AM fluorescent probe workflow to measure mitochondrial pore opening in live cells. This guide connects MPTP detection with patient-derived carpal tunnel models, cell death mechanism research, orthogonal validation, and practical troubleshooting.